All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
Abroad (travel likely)RecruitingPHASE2
Conditions
Glioma · IDH Mutation · Astrocytoma · Oligodendroglioma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Abramson Cancer Center ACC Clinical Trials Navigation) · PMCancerResearch@pennmedicine.upenn.edu · 1-215-349-8245Contact: Principal Investigator (Stephen Bagley, MD, MSCE)
Study leads
Stephen Bagley, MD MSCE
Principal Investigator
University of Pennsylvania